ReviewAnnals of hematology2025

Next-generation Bruton tyrosine kinase inhibitors and degraders in the treatment of B-cell malignancies: advances and challenges.

Yao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.